Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Cisplatin, and Ipilimumab in Metastatic Urothelial Carcinoma
NCT01524991Phase 2Completed
- Sponsor
- Hoosier Cancer Research Network
- Start
- Jan 2012
- Primary completion
- Jul 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ipilimumab in urothelial carcinoma (UC), sponsored by Hoosier Cancer Research Network. Started Jan 2012; status: completed.
02
Drugs
ipilimumab
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01524991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524991.